Skip to main content
SpringerLink
Log in

Farmaci interferenti sul metabolismo epatico dei glicocorticoidi

  • Commissione Farmaci della S.I.E.
  • Interferenze farmacologiche sulla diagnostica ormonale dell’asse ipotalamo-ipofisi-surrene (HPA)
  • Published:
L’Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Orth DN, Kovacs WJ. The adrenal cortex. Williams textbook of endocrinology. 9th Edition, W.B. Saunders Company, 1998.

  2. Ohno M, Yamaguchi I, Ito T, Saiki K, Yamamoto I, Azuma J. Circadian variation of the urinary 6beta-hydroxicortisol to cortisol ratio that would reflect hepatic CYP3A activity. Eur J Clin Pharmacol 55: 861, 2000.

    Article  CAS  PubMed  Google Scholar 

  3. Putignano P, Kaltsas GA, Satta A, Grossman B. The effects of anti-convulsivant drugs on adrenal function. Horm Metab Res 30: 389, 1998.

    Article  CAS  PubMed  Google Scholar 

  4. Terzolo M, Borretta G, Alì A, Cesario F, Magro G, Boccuzzi A, Reimondo G, Angeli A. Misdiagnosis of Cushing’s syndrome in a patient receiving rifampicin therapy for tubercolosis. Horm Metab Res 27: 148, 1995.

    Article  CAS  PubMed  Google Scholar 

  5. Dimaraki EV, Jaffe CA. Troglitazone indices CYP3A4 activity leading to falsely abnormal dexamethasone suppression test. J Clin Endocrinol Metab 88: 3113, 2003.

    Article  CAS  PubMed  Google Scholar 

  6. Varis T, Kivisto KT, Backman JT, Neuvonen PJ. The cytochrome P4503A4 inibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Clin Pharmacol Ther 68: 487, 2000.

    Article  CAS  PubMed  Google Scholar 

  7. Lebrun-Vignes B, Archer VC, Diquet B, Levron JC, Chosidow O, Puech AJ, Warot D. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br J Clin Pharmacol 51: 443, 2001.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Rouanet I, Peyriere H, Mauboussin JM, Vincent D. Cushing’s syndrome in a patient treated by ritonavir/lopinavir and inhaled fluticasone. HIV Med 4: 149, 2003.

    Article  CAS  PubMed  Google Scholar 

  9. Fugh-Berman A. Herb-drug interactions. Lancet 355: 13438, 2000.

    Article  Google Scholar 

  10. Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJ. Herbal bioactivation: the good, the bad and the ugly. Life Sci 74: 935, 2004.

    Article  CAS  PubMed  Google Scholar 

  11. Krapf R. Development of Cushing’s syndrome after use of a herbal remedy. Lancet 360: 1884, 2002.

    Article  PubMed  Google Scholar 

  12. McConkey B. Adrenal corticosteroids in Chinese herbal remedies. Q J Med 96: 81, 2003.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. S.C. di Endocrinologia e Malattie del Ricambio, A.S.O.S. Croce e Carle, Via Coppino 26, 12100, Cuneo, Italia

    Giorgio Borretta & Anna Pia

Authors
  1. Giorgio Borretta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Pia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giorgio Borretta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borretta, G., Pia, A. Farmaci interferenti sul metabolismo epatico dei glicocorticoidi. L’Endocrinologo 9, 88–90 (2008). https://doi.org/10.1007/BF03344615

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344615

Search

Navigation